Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Transcutaneous bilirubin levels in extremely preterm infants less than 30 weeks gestation

Abstract

Objective

The primary objective of this study was to determine the relationship between transcutaneous bilirubin (TcB) levels and total serum bilirubin (TSB) levels in extremely preterm infants.

Study design

We conducted a prospective multicenter study of extremely preterm infants less than 30 weeks gestation in California. Difference between paired TcB and TSB values were compared based on gestational age, birth weight, maternal race/ethnicity, chronological age as well as during and after phototherapy.

Results

TSB values ranged from 0 to 12.6 mg/dl and the TcB values ranged from 0 to 14.2 mg/dl. TSB was predicted with a high degree of accuracy at TSB = 2.37 + 0.54 (TcB) with r = 0.786. There was good correlation across gestational age, birth weight, race/ethnic, chronological age subgroups as well as during and after phototherapy.

Conclusion

Our study supports the use of TcB as a screening tool for monitoring jaundice in extremely preterm infants.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Correlation Graph.
Fig. 2: Bland-Altman plot.
Fig. 3: Box plot of gestational age subgroups.
Fig. 4: Box plot on and off phototherapy.

Similar content being viewed by others

Data availability

Complete de-identified study data that underlie the results reported in the manuscript will be available upon request. Data requests should be directed to the corresponding author.

References

  1. Mitra S, Rennie J. Neonatal Jaundice: Aetiology, diagnosis and treatment. Br J Hosp Med. 2017;78:699–704.

    Article  Google Scholar 

  2. Nagar G, Vandermeer B, Campbell S, Kumar M. Effect of Phototherapy on the Reliability of Transcutaneous Bilirubin Devices in Term and Near-Term Infants: A Systematic Review and Meta-Analysis. Neonatology 2016;109:203–12.

    Article  CAS  Google Scholar 

  3. Counsilman CE, Heeger LE, Tan R, Bekker V, Zwaginga JJ, Te Pas AB, et al. Iatrogenic blood loss in extreme preterm infants due to frequent laboratory tests and procedures. J Matern Fetal Neonatal Med. 2021;34:2660–65.

  4. Nagar G, Vandermeer B, Campbell S, Kumar M. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 2013;132:871–81.

    Article  Google Scholar 

  5. Schmidt ET, Wheeler CA, Jackson GL, Engle WD. Evaluation of transcutaneous bilirubinometry in preterm neonates. J Perinatol. 2009;29:564–9.

    Article  CAS  Google Scholar 

  6. Engle WD, Jackson GL, Engle NG. Transcutaneous bilirubinometry. Semin Perinatol. 2014;38:438–51.

    Article  Google Scholar 

  7. Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 h in a normal newborn population of > or =35 weeks’ gestation. Pediatrics. 2006;117:1169–73.

    Article  Google Scholar 

  8. Maisels MJ, Coffey MP, Kring E. Transcutaneous bilirubin levels in newborns <35 weeks’ gestation. J Perinatol. 2015;35:739–44.

    Article  CAS  Google Scholar 

  9. Maisels MJ. Transcutaneous bilirubin measurement: does it work in the real world? Pediatrics 2015;135:364–6.

    Article  Google Scholar 

  10. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32:660–4.

    Article  CAS  Google Scholar 

  11. Bhatt DR, Kristensen-Cabrera AI, Lee HC, Weerasinghe S, Stevenson DK, Bhutani VK, et al. Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units. J Perinatol. 2018;38:1532–5.

    Article  Google Scholar 

  12. Chawla D, Jain S, Kaur G, Sinhmar V, Guglani V. Accuracy of transcutaneous bilirubin measurement in preterm low-birth-weight neonates. Eur J Pediatr. 2014;173:173–9.

    Article  CAS  Google Scholar 

  13. Chawla D. Transcutaneous Bilirubin for Screening of Significant Jaundice in Very Preterm Neonates. Indian J Pediatr. 2019;86:4.

    Article  Google Scholar 

  14. Raba AA, O’Sullivan A, Miletin J. Transcutaneous bilirubinometry during and after phototherapy in preterm infants: a prospective observational study. BMJ Paediatr Open. 2020;16:4.

    Google Scholar 

  15. Pendse A, Jasani B, Nanavati R, Kabra N. Comparison of Transcutaneous Bilirubin Measurement with Total Serum Bilirubin Levels in Preterm Neonates Receiving Phototherapy. Indian Pediatr. 2017;54:641–3.

    Article  Google Scholar 

  16. Cucuy M, Juster-Reicher A, Flidel O, Shinwell E. Correlation between transcutaneous and serum bilirubin in preterm infants before, during, and after phototherapy. J Matern Fetal Neonatal Med. 2018;10:1323–6.

    Article  Google Scholar 

  17. Bhargava V, Tawfik D, Niebuhr B, Jain SK. Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy: A prospective observational study. BMC Pediatr. 2018;18:22.

    Article  Google Scholar 

  18. Murli L, Thukral A, Sankar MJ, Vishnubhatla S, Deorari AK, Paul VK, et al. Reliability of transcutaneous bilirubinometry from shielded skin in neonates receiving phototherapy: A prospective cohort study. J Perinatol. 2017;37:182–7.

    Article  CAS  Google Scholar 

  19. Costa-Posada U, Concheiro-Guisán A, Táboas-Ledo MF, González-Colmenero E, González-Durán ML, Suarez-Albo M, et al. Accuracy of transcutaneous bilirubin on covered skin in preterm and term newborns receiving phototherapy using a JM-105 bilirubinometer. J Perinatol. 2020;40:226–31.

    Article  CAS  Google Scholar 

  20. De Luca D, Dell’Orto V. Patched skin bilirubin assay to monitor neonates born extremely preterm undergoing phototherapy. J Pediatr. 2017;188:122–7.

    Article  Google Scholar 

  21. Fonseca R, Kyralessa R, Malloy M, Richardson J, Jain SK. Covered skin transcutaneous bilirubin estimation is comparable with serum bilirubin during and after phototherapy. J Perinatol. 2012;32:129–31.

    Article  CAS  Google Scholar 

  22. Rubio A, Epiard C, Gebus M, Deiber M, Samperiz S, Genty C, et al. Diagnosis Accuracy of Transcutaneous Bilirubinometry in Very Preterm Newborns. Neonatology. 2017;111:1–7.

    Article  CAS  Google Scholar 

  23. Arman D, Topcuoğlu S, Gürsoy T, Ovalı F, Karatekin G. The accuracy of transcutaneous bilirubinometry in preterm infants. J Perinatol. 2020;40:212–8.

    Article  CAS  Google Scholar 

  24. Yaser A, Tooke L, Rhoda N. Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. J Perinatol. 2014;34:209–12.

    Article  CAS  Google Scholar 

  25. Jeon J, Lim G, Oh KW, Lee NM, Park HW, Chung ML. The forehead is a better site than the sternum to check transcutaneous bilirubin during phototherapy in sick infants. BMC Pediatr. 2020;20:548.

    Article  CAS  Google Scholar 

  26. Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, et al. NICHD Neonatal Research Network. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N. Engl J Med. 2008;359:1885–96.

    Article  CAS  Google Scholar 

  27. Kaplan M, Bromiker R. Variation in transcutaneous bilirubin nomograms across population groups. J Pediatr. 2019;208:273–8.

    Article  Google Scholar 

  28. Konana OS, Bahr TM, Strike HR, Coleman J, Snow GL, Christensen RD. Decision accuracy and safety of transcutaneous bilirubin screening at intermountain healthcare. J Pediatr. 2021;228:53–57.

    Article  CAS  Google Scholar 

  29. Van den Esker-Jonker B, den Boer L, Pepping RM, Bekhof J. Transcutaneous bilirubinometry in jaundiced neonates: A randomized controlled Trial. Pediatrics. 2016;138:e2016–2414.

    Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Jeffrey Maisels for his expert input and guidance. The authors thank Joanne Kuller, Clinical nurse specialist, UCSF Benioff Children’s Oakland & Marcie Portillo, Neonatal Research Institute, Sharp Mary Birch Women & Children’s Hospital for their assistance with the data collection process at their respective centers. We also would like to thank Dr. Robert Kahle, Past President, California Association of Neonatologists (CAN) and CAN Research Committee members for their support with this study.

Funding

The authors received no funding to conduct this study.

Author information

Authors and Affiliations

Authors

Contributions

MNS, RR and DRB conceptualized and designed the study. MNS designed the study protocol, data collection documents and coordinated the study. AK, PJ, MFV, MC, VP, HT, RCT, VA and MN collected study data. MB analyzed study data and created tables and figures for the study. MNS wrote the initial version of the manuscript and MB, RR, AK, PJ, VA, RCT, HT, VP, MV, DRB, MC & MN critically reviewed and revised the manuscript.

Corresponding author

Correspondence to Meera. N. Sankar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sankar, M.N., Ramanathan, R., Joe, P. et al. Transcutaneous bilirubin levels in extremely preterm infants less than 30 weeks gestation. J Perinatol 43, 220–225 (2023). https://doi.org/10.1038/s41372-022-01477-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-022-01477-4

Search

Quick links